• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Bioengineering

FDA to study “three-parent embryos”

Bioengineer by Bioengineer
March 1, 2014
in Bioengineering
Reading Time: 1 min read
1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

On February 25 and 26 the US Food and Drug Administration discussed the possibility of legalising three-parent embryos – or, in scientific lingo, “oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility”.

FDA to study three-parent embryos

This procedure, which involves removing the nucleus from one human egg whose cytoplasm contains defective mitochondria and placing it in an enucleated egg with healthy DNA for subsequent fertilisation, is also being debated in the UK.

The measure is strongly opposed by the Center for Genetics and Society, which is promoting an open letter to the FDA. It claims that mitochondrial transfer is unsafe, is effectively experimentation on unconsenting human subjects, and would only help a handful of women. Most importantly, it constitutes germline modification, a form of eugenics. This is a bright line which no country has ever stepped across.

Story Source:

The above story is based on materials provided by bioedge, Michael Cook.

Share12Tweet8Share2ShareShareShare2

Related Posts

Why is the first Turkish bioengineering promotion website, Biyomuhendislik.com, so important?

February 4, 2023

Robo-fish

September 19, 2016

Mice born from ‘tricked’ eggs

September 17, 2016

UCLA researchers use stem cells to grow 3-D lung-in-a-dish

September 16, 2016
Please login to join discussion

POPULAR NEWS

  • Needlestick Injury Rates in Nurses and Students in Pakistan

    297 shares
    Share 119 Tweet 74
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    155 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    118 shares
    Share 47 Tweet 30

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sugar-coated nanoparticles show promise in targeting deadly breast cancer

Boosting Adolescent Engagement in Eating Disorder Treatment

SERAPHINA Study: Nab-Paclitaxel Benefits in HER2-Negative Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.